Patents by Inventor Scott Baldwin McCray

Scott Baldwin McCray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110027372
    Abstract: Multiparticulates of low-solubility drugs and carriers that result in rapid release of the drug are disclosed.
    Type: Application
    Filed: October 11, 2010
    Publication date: February 3, 2011
    Inventors: Leah Elizabeth Appel, Dwayne Thomas Friesen, David Keith Lyon, Scott Baldwin McCray, Joshua Richard Shockey
  • Publication number: 20100089186
    Abstract: A membrane-permeation test for evaluating pharmaceutical compositions is described. The method comprises the following steps: (1) providing a microporous membrane having a plurality of pores, the membrane having a feed side and a permeate side, wherein the feed side of the membrane is in fluid communication with the feed solution, and wherein the permeate side of the membrane is in fluid communication with a permeate solution; (2) administering a pharmaceutical composition to an aqueous solution to form a feed solution; and (3) measuring the concentration of drug in the permeate solution; wherein the feed side of the membrane is hydrophilic, and/or wherein the permeate solution comprises an organic fluid.
    Type: Application
    Filed: November 2, 2009
    Publication date: April 15, 2010
    Inventors: Walter Christian Babcock, Dwayne Thomas Friesen, Scott Baldwin McCray
  • Patent number: 7611630
    Abstract: A membrane-permeation test for evaluating pharmaceutical compositions is described. The method comprises the following steps: (1) providing a microporous membrane having a plurality of pores, the membrane having a feed side and a permeate side, wherein the feed side of the membrane is in fluid communication with the feed solution, and wherein the permeate side of the membrane is in fluid communication with a permeate solution; (2) administering a pharmaceutical composition to an aqueous solution to form a feed solution; and (3) measuring the concentration of drug in the permeate solution; wherein the feed side of the membrane is hydrophilic, and/or wherein the permeate solution comprises an organic fluid.
    Type: Grant
    Filed: March 18, 2005
    Date of Patent: November 3, 2009
    Assignee: Bend Research, Inc.
    Inventors: Walter Christian Babcock, Dwayne Thomas Friesen, Scott Baldwin McCray
  • Publication number: 20090142401
    Abstract: Multiparticulates of low-solubility drugs and carriers that result in rapid release of the drug are disclosed.
    Type: Application
    Filed: May 26, 2006
    Publication date: June 4, 2009
    Inventors: Leah Elizabeth Appel, Dwayne Thomas Friesen, David Keith Lyon, Scott Baldwin McCray, Joshua Richard Shockey
  • Patent number: 6984403
    Abstract: The present invention is related to an oral dosage form comprising an effective amount of an alkalizing agent and an azithromycin multiparticulate wherein said multiparticulate comprises azithromycin, a glyceride which comprises glyceryl monobehenate, glyceryl dibehenate, glyceryl tribehenate, or a mixture thereof and a poloxamer. Typically, the oral dosage form includes any suitable oral dosing means such as a powder for oral suspension, a unit dose packet or sachet, a tablet or a capsule.
    Type: Grant
    Filed: January 23, 2004
    Date of Patent: January 10, 2006
    Assignee: Pfizer Inc.
    Inventors: Timothy A. Hagen, Julian B. Lo, Avinash G. Thombre, Scott M. Herbig, Leah Elizabeth Appel, Marshall David Crew, Dwayne Thomas Friesen, David Keith Lyon, Scott Baldwin McCray, James Blair West